Pengembangan dan Profil Farmakokinetik Senyawa Turunan Pirazolo-(3,4-D)-Pirimidin Sebagai Inhibitor Mer Secara Insilico
Abstract
The Mer receptor is an important target for development of molecular probes in oncology because just expressed by T cell Acute Leukemia Lymphboblastic and not expressed by T-cell normal and a ATP kinase competitive inhibitor. The purpose of this research is development derivate Pyrazolo-[3,4-D]-pyrimidin then choose candidate active and selective chemicals for Mer receptor to be a treatment for acute leukemi lymphoblastic by insilico. Procedures are began with modelingand geometry optimization of molecular structure which made by HyperChem 8.0. Geometry optimization was performed by Ab initio method. QSAR descriptors were calculated by MOE 2009. The next step is determine pharmacokinetic profile with AdmetSAR and DemPred. Based on pharmacokinetic predictions overall koefisian compounds have the same choice 1.0000 on human intestinal
absorption can be absorbed properly. the most well permeabiltas Caco2 cells are compounds 008 and 115. Compounds 008 and 115 also has the lowest coefficient on thepenetration of blood brain barrier. Compounds 008 and 115 have the smallest volume of distribution is 2.400352 L / kg means that the volume of the compounds 008 and 115.Compounds with the best clearance of compounds 001 and 111 with a clearan of 2.058811 ml / min / kg.References
Chandrayani, Gambaran Epdemologi Leukimia Anak Yang Dirawat Di Rksd Dari Tahun 2004-2008, Jakarta : FKMUI, 2009.
Liu, J., Yang, C., Simpson, C., DeRyckere, D., Van Deusen,A., Miley, M.,J., Kireev, D., Norris-Drouin, J., Sather, S., Hunter,D., Korboukh, V.K., Patel, H.S., Janzen, W.P., Machius, M., Johnson, G.L., Earp, H.S., Graham, D.K., Frye, S.V., Wang, X., 2012, Discovery of Small Molecule Mer Kinase Inhibitors for the Treatment of Pediatric Acute Lymphoblastic Leukemia, Med. Chem. Lett., 3(2), 129- 134
Nursalam, Studi Hubungan Kuantitati Strukturaktivitas, Fitur Farmakofor Dan Docking Molekuler Senyawa Turunan Pirazolo-[3,4-D]-Pirimidin Sebagai Inhibitor Mer Tirosin Kinase, Institut Teknologi Bandung, Bandung, 2013.
Rahmawati Dede Riska, Penyesuaian Diri
Anak Penderita Leukimia Terhadap Hospitalisasi, Universitas Pendidikan Indonesia, Jakarta, 2013.
Rachel M. A. Linger, Amy K. Keating, H. Shelton Earp, dan Douglas K. Graham, TAM Receptor Tyrosine Kinases: Biologic Functions, Signaling,and Potential Therapeutic Targeting in Human Cancer, 100, Department of Pediatrics, University of Colorado at Denver and Health Sciences Center, Aurora,CO, 2008.